Mutations of RAS proto-oncogenes (HRAS, NRAS, KRAS4A, and KRAS4B) are among the most common genetic alterations observed in human cancer (Punekar et al, 2022; Simanshu et al, 2017). The gene discussed is NRAS; the disease is cancer.